Fleur A. de Groot

Frequent mutated <i>B2M</i>, <i>EZH2</i>, <i>IRF8</i>, and <i>TNFRSF14</i> in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

Ruben A. L. de Groen, Ronald van Eijk, Stefan Böehringer et al. · Blood Advances · 2021 · 17 citations · Full text

Medicine, Hematology, Oncology +16

Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas

Lorraine M. de Haan, Ruben A. L. de Groen, Fleur A. de Groot et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2023 · 14 citations · Full text

Medicine, Oncology, Pathology +17

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies

Fleur A. de Groot, Tim Dekker, Jeanette K. Doorduijn et al. · European Journal of Cancer · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

Patrick René Gerhard Eriksen, Fleur A. de Groot, Erik Clasen‐Linde et al. · Blood Advances · 2024 · 10 citations · Full text

Medicine, Oncology, Pathology +17